Agilon Health (AGL) Return on Invested Capital (2021 - 2025)
Agilon Health (AGL) has disclosed Return on Invested Capital for 5 consecutive years, with 1.95% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Invested Capital fell 142.0% year-over-year to 1.95%, compared with a TTM value of 1.95% through Dec 2025, down 142.0%, and an annual FY2025 reading of 1.33%, down 86.0% over the prior year.
- Return on Invested Capital was 1.95% for Q4 2025 at Agilon Health, down from 0.89% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.07% in Q3 2022 and bottomed at 1.95% in Q4 2025.
- Average Return on Invested Capital over 5 years is 0.45%, with a median of 0.34% recorded in 2021.
- The sharpest move saw Return on Invested Capital soared 77bps in 2022, then crashed -142bps in 2025.
- Year by year, Return on Invested Capital stood at 0.33% in 2021, then soared by 70bps to 0.1% in 2022, then plummeted by -182bps to 0.28% in 2023, then tumbled by -87bps to 0.53% in 2024, then crashed by -268bps to 1.95% in 2025.
- Business Quant data shows Return on Invested Capital for AGL at 1.95% in Q4 2025, 0.89% in Q3 2025, and 0.65% in Q2 2025.